Osteosarcoma in Children Clinical Trial
Official title:
3D Printed Personalized Extendable Prosthesis Replacement for Limb Preservation in Children With Osteosarcoma: a Preliminary Study
Verified date | March 2023 |
Source | Children's Hospital of Chongqing Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this type of observational study is to investigate the preliminary effect of 3D printed personalized extendable prosthesis replacement on limb salvage in children with osteosarcoma. The main question it aims to answer is: Is 3D printed personalized extendable prosthesis replacement has a good outcome in limb salvage pediatric osteosarcoma?
Status | Completed |
Enrollment | 25 |
Est. completion date | March 1, 2023 |
Est. primary completion date | January 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Years to 18 Years |
Eligibility | Inclusion Criteria: - tumors of the extremities, with moderate soft-tissue invasion - the neurovascular bundle is not invaded, and the tumor can be excised totally - no metastatic lesions or metastases can be cured Exclusion Criteria: - recurrent tumors - poorly differentiated tumors - poor soft-tissue conditions - neurovascular invasion around tumors - ineffective chemotherapy with metastasis |
Country | Name | City | State |
---|---|---|---|
China | Children's Hospital of Chongqing Medical University | Chongqing | Chongqing |
Lead Sponsor | Collaborator |
---|---|
Yuxi Su |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recurrence | Osteosarcoma recurrence rate | 7years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03628209 -
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
|
Phase 1/Phase 2 | |
Suspended |
NCT05558280 -
Qarziba for Patients in Relapsed/Refractory High-grade Osteosarcoma
|
Phase 2 | |
Completed |
NCT04644913 -
Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without Radiotherapy
|
||
Active, not recruiting |
NCT04803877 -
SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
|
Phase 2 | |
Not yet recruiting |
NCT06341712 -
Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma
|
Phase 2 | |
Terminated |
NCT03139318 -
Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity
|
N/A | |
Recruiting |
NCT05107843 -
Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric Osteosarcomas
|